David Mason
Impact in
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Autoimmune and Inflammatory Disorders Research 4
-
- Stroke Rehabilitation and Recovery 2
- Co-authors
- William J. SandbornStefan SchreiberRalph BloomfieldPaul RutgeertsBrian G. FeaganS StoĭnovPhilip J. MeaseRonald van Vollenhoven
- Journals
- Gastroenterology (2 papers)The Thoracic and Cardiovascular Surgeon (1 paper)Journal of Thoracic Oncology (1 paper)Annals of the Rheumatic Diseases (1 paper)Neurology (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
David Mason
19 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Rheumatology 842
- Hematology 471
- Genetics 909
- Immunology 600
- Genetics 245
Countries citing papers authored by David Mason
This map shows the geographic impact of David Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Mason more than expected).
Fields of papers citing papers by David Mason
This network shows the impact of papers produced by David Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Mason. The network helps show where David Mason may publish in the future.
Co-authors
The 25 scholars most cited alongside David Mason, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 159 | |
| 2 | 2012 | 3 | |
| 3 | 2012 | 8 | |
| 4 | 2009 | 104 | |
| 5 | Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty‐two–week, phase III, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study Hit paper breakdown → | 2008 | 465 |
| 6 | 2008 | 399 | |
| 7 | 2008 | 4 | |
| 8 | 2008 | 2 | |
| 9 | Certolizumab Pegol for the Treatment of Crohn's Disease Hit paper breakdown → | 2007 | 863 |
| 10 | 2004 | 132 | |
| 11 | Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans. | 2003 | 111 |
| 12 | Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation. | 2002 | 10 |
| 13 | Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. | 2002 | 118 |
| 14 | 2000 | 21 | |
| 15 | 1998 | 74 | |
| 16 | 1997 | 173 | |
| 17 | 1989 | 1 | |
| 18 | 1977 | 19 | |
| 19 | 1976 | 32 |
About David Mason
David Mason is a scholar working on Hematology, Rehabilitation, Genetics, Rheumatology and Psychiatry and Mental health, having authored 19 papers that have together received 2.7k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (5 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Stroke Rehabilitation and Recovery (2 papers), Eosinophilic Esophagitis (2 papers), Spinal Cord Injury Research (2 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). The work is most often cited by research in Rheumatology (842 citations), Hematology (471 citations), Genetics (909 citations), Immunology (600 citations) and Genetics (245 citations). David Mason has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include William J. Sandborn, Stefan Schreiber, Ralph Bloomfield, Paul Rutgeerts, Brian G. Feagan, S Stoĭnov, Philip J. Mease, Ronald van Vollenhoven, Désirée van der Heijde and Vibeke Strand. Their work appears in journals such as Gastroenterology, The Thoracic and Cardiovascular Surgeon, Journal of Thoracic Oncology, Annals of the Rheumatic Diseases and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.